Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Brachytherapy|July 24, 2025
High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statementSagar A Patel, Marisa Kollmeier, Juanita Crook, et al.
Nature Medicine|June 4, 2021
Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancerChris McIntosh, Leigh Conroy, Michael C Tjong, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2024
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled TrialRachel M Glicksman, Srinivas Raman, Xiang Y Ye, et al.
BMC Cancer|April 20, 2023
The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER)Lucas C Mendez, Aneesh Dhar, David Laidley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2022
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?Rohann J M Correa, Gerard Morton, Hans T Chung, et al.
Frontiers in Oncology|September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Frontiers in Oncology|December 5, 2022
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2019
Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trialsYasir Alayed, Harvey Quon, Patrick Cheung, et al.
Pageof 7